Free Trial

Amplify Weight Loss Drug & Treatment ETF (THNR) Short Interest Ratio & Short Volume

$22.59 -0.07 (-0.31%)
As of 04:10 PM Eastern

Amplify Weight Loss Drug & Treatment ETF Short Interest Data

Amplify Weight Loss Drug & Treatment ETF (THNR) has a short interest of 7,000 shares, representing 5.38% of the float (the number of shares available for trading by the public). This marks a 94.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 1,782 shares to cover all short positions.

Current Short Interest
7,000 shares
Previous Short Interest
3,600 shares
Change Vs. Previous Month
+94.44%
Dollar Volume Sold Short
$164.85 thousand
Short Interest Ratio
3.2 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
130,000 shares
Short Percent of Float
5.38%
Today's Trading Volume
1,345 shares
Average Trading Volume
1,782 shares
Today's Volume Vs. Average
75%
Short Selling Amplify Weight Loss Drug & Treatment ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

THNR Short Interest Over Time

THNR Days to Cover Over Time

THNR Percentage of Float Shorted Over Time

Amplify Weight Loss Drug & Treatment ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/20257,000 shares $164.85 thousand +94.4%5.4%3.2 $23.55
5/31/20253,600 shares $79.78 thousand +3,500.0%2.8%1.8 $22.16
5/15/2025100 shares $2.14 thousand -50.0%N/A0.1 $21.40
4/30/2025200 shares $4.40 thousand +100.0%N/A0.1 $22.02
4/15/2025100 shares $2.01 thousand -66.7%N/A0.1 $20.14
3/14/2025100 shares $2.25 thousand -50.0%N/A0.1 $22.47
2/14/2025100 shares $2.25 thousand No ChangeN/A0.1 $22.49
1/31/2025100 shares $2.31 thousand -90.9%N/A0.1 $23.13

THNR Short Interest - Frequently Asked Questions

What is Amplify Weight Loss Drug & Treatment ETF's current short interest?

Short interest is the volume of Amplify Weight Loss Drug & Treatment ETF shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 3,600 shares of THNR short. 2.77% of Amplify Weight Loss Drug & Treatment ETF's shares are currently sold short. Learn More on Amplify Weight Loss Drug & Treatment ETF's current short interest.

What is a good short interest ratio for Amplify Weight Loss Drug & Treatment ETF?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. THNR shares currently have a short interest ratio of 2.0. Learn More on Amplify Weight Loss Drug & Treatment ETF's short interest ratio.

What is a good short interest percentage for Amplify Weight Loss Drug & Treatment ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.77% of Amplify Weight Loss Drug & Treatment ETF's floating shares are currently sold short.

Is Amplify Weight Loss Drug & Treatment ETF's short interest increasing or decreasing?

Amplify Weight Loss Drug & Treatment ETF saw a increase in short interest in May. As of May 31st, there was short interest totaling 3,600 shares, an increase of 3,500.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Amplify Weight Loss Drug & Treatment ETF's short interest compare to its competitors?

2.77% of Amplify Weight Loss Drug & Treatment ETF's shares are currently sold short. Here is how the short interest of companies compare to Amplify Weight Loss Drug & Treatment ETF: ProShares Decline of the Retail Store ETF (0.32%), iShares Breakthrough Environmental Solutions ETF (0.25%), iShares Neuroscience and Healthcare ETF (1.20%), ProShares Ultra Nasdaq Cloud Computing ETF (0.11%), Tema Luxury ETF (0.50%), Global X Interest Rate Hedge ETF (1.00%), SPDR MSCI USA Climate Paris Aligned ETF (0.25%), Global X Disruptive Materials ETF (0.77%), First Trust Nasdaq Lux Digital Health Solutions ETF (0.20%), AdvisorShares Restaurant ETF (1.83%), and

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short Amplify Weight Loss Drug & Treatment ETF stock?

Short selling THNR is an investing strategy that aims to generate trading profit from Amplify Weight Loss Drug & Treatment ETF as its price is falling. THNR shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Amplify Weight Loss Drug & Treatment ETF?

A short squeeze for Amplify Weight Loss Drug & Treatment ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of THNR, which in turn drives the price of the stock up even further.

How often is Amplify Weight Loss Drug & Treatment ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THNR, twice per month. The most recent reporting period available is May, 31 2025.




This page (NYSEARCA:THNR) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners